Details for Patent: 7,119,061
✉ Email this page to a colleague
Summary for Patent: 7,119,061
| Title: | Dalbavancin compositions for treatment of bacterial infections |
| Abstract: | The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of dalbavancin formulations for treatment of a bacterial infection, in particular a Gram-positive bacterial infection of skin and soft tissue. Dosing regimes include once weekly administration of dalbavancin, which often remains at therapeutic levels in the bloodstream for at least one week, providing prolonged therapeutic action against a bacterial infection. |
| Inventor(s): | Stogniew; Martin (Blue Bell, PA) |
| Assignee: | Vicuron Pharmaceuticals, Inc. (King of Prussia, PA) |
| Application Number: | 10/834,395 |
|
Patent Claim Types: see list of patent claims | Formulation; |
More… ↓ |
Drugs Protected by US Patent 7,119,061
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,119,061
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2003294262 | ⤷ Subscribe | |||
| Australia | 2003298662 | ⤷ Subscribe | |||
| Australia | 2003299561 | ⤷ Subscribe | |||
| Australia | 2005325261 | ⤷ Subscribe | |||
| Australia | 2011200423 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
